Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Christopher K. Mirabelli

President, DecImmune and Managing Director, Health
Life Science
DecImmune Therapeutics
United States of America


Dr. Mirabelli joined HealthCare Ventures in 2000 and is a Managing Director at the firm. Dr. Mirabelli was Chairman of the Board and Chief Executive Officer of LeukoSite, Inc. from 1993 through 1999, a company in which HealthCare Ventures was the lead investor. Dr. Mirabelli was also a co-founder of Isis Pharmaceuticals and served with SmithKline and French Laboratories R&D Division. Dr. Mirabelli received his doctorate in molecular pharmacology from Baylor College of Medicine. 

Research Interest

Acute inflammation, Irreversible tissue damage, Scar formation, and Loss of tissue functionality. 

Global Experts from United States of America

Global Experts in Subject

Share This Profile